Mapping susceptibility genes for bipolar disorder: A pharmacogenetic approach based on excellent response to lithium

Molecular Psychiatry

Volumn 6, Issue 5, 2001, Pages 570-578

  Turecki, G ^a   Grof, P ^b   Grof, E ^b   D'souza, V ^a   Lebuis, L ^a   Marineau, C ^a   Cavazzoni, P ^b   Duffy, A ^b   Betard C ^c   Zvolsky P ^d   Robertson, C ^e   Brewer, C ^c   Hudson, T J ^c   Rouleau, G A ^a   Alda, M ^b,f  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d CHARLES UNIVERSITY   (Czech Republic)

^e ROYAL OTTAWA HOSPITAL   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Bipolar disorder; Chromosome 15; Chromosome 7; Genome scan; Linkage analysis; Lithium response

Indexed keywords

LITHIUM;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 15; CHROMOSOME 7; CLINICAL ARTICLE; FAMILY HISTORY; FEMALE; GENE MAPPING; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS;

ADULT; AGE OF ONSET; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; FOLLOW-UP STUDIES; GENES, DOMINANT; GENES, RECESSIVE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); LITHIUM; MALE; MIDDLE AGED; MODELS, GENETIC; MODELS, STATISTICAL; SOFTWARE; TIME FACTORS;

EID: 17944371887     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000888     Document Type: Article

References (44)

1. Drug reactions, enzymes and biochemical genetics
2. Pharmacogenetics in biological perspective
3. Pharmacogenetics of antide-pressants: Clinical aspects
4. Genetic variation in susceptibility to endocrine disruption by estrogen in mice
5. Does lithium treatment still work? Evidence of stable responses over three decades
6. Unanswered questions, unknown future for one of our oldest medications
7. Current therapeutic profile of lithium
8. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection
9. Lithium effects on neuroendocrine function
10. Relationship between the effectiveness of lithium therapy and family history
11. Genealogic study of patients suffering from primary affective disorder and treated with lithium
12. Family history of manic depressive and endogenous depressive patients and clinical effects of treatment with lithium
13. Prediction of treatment outcome: Family and twin studies in lithium prophylaxis and the question of lithium red blood cell/plasma ratios
14. Outcomes on lithium treatment as a tool for genetic studies in affective disorders
15. Lithium response and genetics of affective disorders
16. Mode of inheritance in families of patients with lithium-responsive affective disorders
17. Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis?
18. Ascertainment in the sequential sampling of pedigrees
19. A diagnostic interview: The schedule for affective disorders and schizophrenia
20. Research diagnostic criteria: Rationale and reliability
21. Sets of short tandem repeat polymorphisms for efficient linkage screening of the human genome
22. A comprehensive genetic map of the human genome based on 5264 microsatellites
23. Strategies for multilocus linkage analysis in humans
24. Faster sequential genetic linkage computations
25. Computer-simulation methods in human linkage analysis
26. SLINK: A general simulation program for linkage analysis
27. Nonparametric simulation-based statistics for detecting linkage in general pedigrees
28. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
29. Further evidence for the increased power of LOD scores compared with nonparametric methods
30. Association between the GABA(A) receptor alpha5 subunit gene locus (GABRA5) and bipolar affective disorder
31. Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3
32. A genome-wide search for chromosomal loci linked to bipolar affective disorder in the Old Order Amish
33. A case of bipolar disorder with balanced chromosomal translocation
34. Linkage analysis between manic-depressive illness and the region on chromosome 15q involved in Prader-Willi syndrome including two GABAA receptor subtype genes
35. Chromosomal aberrations and bipolar affective disorder
36. Autism, profound mental retardation and atypical bipolar disorder in a 33-year-old female with a deletion of 15q12
37. Chromosome workshop: Chromosomes 11, 14, and 15
38. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
39. Are schizophrenic and bipolar disorders related? A review of family and molecular studies
40. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease
41. Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder